Citius Pharma (CTXR). Reports Fiscal First Quarter 2023 Financial Results and Provides Business Update
$36.9 million in cash and cash equivalents as of December 31, 2022 ; runway through February 2024
Uptick in patient recruitment for Mino-Lok® Phase 3 trial
Halo-Lido Phase 2b trial nearing completion
CRANFORD,...
Ohio State University Completes Study on Pressure Bioscience (PBIO) and Protein Drinks.
Pressure BioSciences' Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market.
Recent Study Published by The Ohio...
Interview: Ric Schumacher CEO, Pressure Bioscience (PBIO)
Our favorite interview to date, and there have been dozens. Filmed November of 2021, and the story has gotten to much better since.
https://vimeo.com/652106617
$PBIO,...
Latest article
Annette L. Redmond Joins Strategic Advisory Board at Sekur Private Data (SWISF).
Former U.S. State Department Deputy Assistant Secretary
Decorated intelligence and cybersecurity executive with four decades of U.S. government leadership joins Sekur to advise on secure...
10X Alerts: Sekur Private Data (SWISF) Pushes SekurOne Closer to Market With First International...
Sekur has completed its first domestic and international encrypted calls on SekurOne and launched the platform’s voice, email, messenger, and VPN capabilities on Android...
Could a Record El Niño Ignite the Next Vaccine Trade?
Chikungunya, Dengue Fever, Rift Valley Fever and Zika
The Coming El Niño: An Overlooked Catalyst for Vaccine Stocks?
Investors obsess over interest rates, tariffs and AI....
